Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Sample Size Considerations in Clinical Trials when Comparing Two Interventions using Multiple Co-Primary Binary Relative Risk Contrasts.

Ando Y, Hamasaki T, Evans SR, Asakura K, Sugimoto T, Sozu T, Ohno Y.

Stat Biopharm Res. 2015 Jun 24;7(2):81-94.

2.

Reducing unnecessary measurements in clinical trials with multiple primary endpoints.

Sozu T, Sugimoto T, Hamasaki T.

J Biopharm Stat. 2016;26(4):631-43. doi: 10.1080/10543406.2015.1052497. Epub 2015 Jun 22.

PMID:
26098617
3.

Sample size determination in group-sequential clinical trials with two co-primary endpoints.

Asakura K, Hamasaki T, Sugimoto T, Hayashi K, Evans SR, Sozu T.

Stat Med. 2014 Jul 30;33(17):2897-913. doi: 10.1002/sim.6154. Epub 2014 Mar 27.

Supplemental Content

Loading ...
Support Center